Ritlecitinib (tosylate) (Standard), CAS [[2192215-81-7]] Preis auf Anfrage

Produktübersicht

• Artikelname: Ritlecitinib (tosylate) (Standard), CAS [[2192215-81-7]] Preis auf Anfrage
• Artikelnummer: MCE-HY-100754CR
• Hersteller Artikelnummer: HY-100754CR
• Alternativnummer: MCE-HY-100754CR-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Ritlecitinib (tosylate) (Standard) is the analytical standard of Ritlecitinib (tosylate) (HY-100754C). This product is intended for research and analytical applications. Ritlecitinib (PF-06651600) tosylate is a highly selective, orally active, irreversible covalent JAK3 inhibitor (IC50=33 nM) without inhibitory activity towards JAK1, JAK2, and TYK2 (IC50 >10 µ M). Ritlecitinib tosylate rapidly inactivates the JAK3 kinase, and blocks signaling and downstream STAT phosphorylation mediated by common gamma chain cytokines such as IL-2 and IL-15. Ritlecitinib tosylate can inhibit Th1/Th17 cell differentiation and function, and effectively suppress preclinical animal models such as alopecia areata, adjuvant-induced arthritis (AIA), and experimental autoimmune encephalomyelitis (EAE)[1][2][3].

Produkteigenschaften

• Molekulargewicht: 457.55
• CAS Nummer: [2192215-81-7]
• Formel: C22H27N5O4S
• Target-Kategorie: Interleukin Related,JAK,Reference Standards,STAT

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference Standards